TScan Therapeutics, Inc. (TCRX) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
TCRX Historical Performance
Short-Term Returns
TCRX Stock Price Trajectory (2021–2026)
As of May 8, 2026, TScan Therapeutics, Inc. (TCRX) trades at $1.21, representing a -11.0% return over the past year. The stock has delivered a -88.5% total return over five years (-35.1% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $14.71 on August 18, 2021. From this peak, TCRX has corrected -91.8%, currently trading 12% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers IMVT (+96.1% 1Y), TCRT (-7.1% 1Y), and AGEN (+27.1% 1Y), TCRX has underperformed the peer group average. Compare TCRX vs IMVT →
TCRX Historical Price Data (2025–2026)
Showing 30 of 1,209 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.23 | 1.29 | 1.16 | 1.21 | 802K | -3.20% |
| 2026-05-06 | 1.19 | 1.26 | 1.19 | 1.25 | 978K | +3.31% |
| 2026-05-05 | 1.24 | 1.25 | 1.18 | 1.21 | 930K | -0.82% |
| 2026-05-04 | 1.23 | 1.28 | 1.20 | 1.22 | 452K | 0.00% |
| 2026-05-01 | 1.16 | 1.24 | 1.14 | 1.22 | 616K | +5.17% |
| 2026-04-30 | 1.15 | 1.20 | 1.14 | 1.16 | 424K | +0.87% |
| 2026-04-29 | 1.25 | 1.25 | 1.13 | 1.15 | 503K | -8.73% |
| 2026-04-28 | 1.25 | 1.32 | 1.25 | 1.26 | 500K | -3.82% |
| 2026-04-27 | 1.25 | 1.35 | 1.25 | 1.31 | 936K | +3.97% |
| 2026-04-24 | 1.23 | 1.26 | 1.17 | 1.26 | 1.07M | +5.00% |
| 2026-04-23 | 1.26 | 1.27 | 1.16 | 1.20 | 1.26M | -4.00% |
| 2026-04-22 | 1.28 | 1.32 | 1.23 | 1.25 | 741K | -1.57% |
| 2026-04-21 | 1.40 | 1.40 | 1.26 | 1.27 | 1.28M | -11.19% |
| 2026-04-20 | 1.17 | 1.47 | 1.17 | 1.43 | 2.86M | +20.17% |
| 2026-04-17 | 1.12 | 1.20 | 1.11 | 1.19 | 1.24M | +10.19% |
| 2026-04-16 | 1.08 | 1.10 | 1.05 | 1.08 | 1.24M | +0.93% |
| 2026-04-15 | 1.05 | 1.07 | 1.03 | 1.07 | 987K | +0.94% |
| 2026-04-14 | 1.03 | 1.07 | 1.02 | 1.06 | 1.21M | +3.92% |
| 2026-04-13 | 1.05 | 1.08 | 1.00 | 1.02 | 7.20M | -2.86% |
| 2026-04-10 | 1.06 | 1.09 | 1.01 | 1.05 | 1.12M | -0.94% |
| 2026-04-09 | 1.06 | 1.08 | 1.03 | 1.06 | 665K | 0.00% |
| 2026-04-08 | 1.16 | 1.16 | 1.05 | 1.06 | 951K | -0.93% |
| 2026-04-07 | 1.05 | 1.09 | 1.02 | 1.07 | 1.50M | +2.88% |
| 2026-04-06 | 1.04 | 1.08 | 1.03 | 1.04 | 806K | +2.97% |
| 2026-04-02 | 1.00 | 1.05 | 1.00 | 1.01 | 673K | -1.94% |
| 2026-04-01 | 0.99 | 1.07 | 0.99 | 1.03 | 636K | +1.98% |
| 2026-03-31 | 0.97 | 1.02 | 0.96 | 1.01 | 232K | +7.41% |
| 2026-03-30 | 1.00 | 1.00 | 0.92 | 0.94 | 298K | -4.88% |
| 2026-03-27 | 1.02 | 1.02 | 0.97 | 0.99 | 459K | -4.03% |
| 2026-03-26 | 1.04 | 1.06 | 1.01 | 1.03 | 314K | -0.96% |
See TCRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TCRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TCRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTCRX — Frequently Asked Questions
Quick answers to the most common questions about buying TCRX stock.
How has TCRX stock performed recently?
TCRX declined -11.0% over the past year, below its 5-year annualized CAGR of -35.1%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is TCRX's all-time high price?
TScan Therapeutics, Inc. reached $14.71 on 2021-08-18. The 52-week high is $2.57. Current 1-year return of -11.0% places the stock further from historical peaks.
Where can I download TCRX historical price data?
This page provides TCRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.